Understanding genetic factors in hereditary paraganglioma and pheochromocytoma syndrome
Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
This study is looking at how certain genes might affect the chances of developing adrenal tumors called paragangliomas and pheochromocytomas, so if you or someone you know is at risk, this research could help improve testing and treatment options for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10834053 on NIH RePORTER |
What this research studies
This research investigates the genetic variations that contribute to hereditary paraganglioma and pheochromocytoma syndrome, which are types of tumors that can affect the adrenal glands. The study aims to identify specific genetic markers that can predict the likelihood of developing these tumors and their potential for metastasis. By analyzing the Succinate Dehydrogenase Subunit (SDH) genes and their role in tumor development, the research seeks to improve screening and surveillance recommendations for at-risk individuals. Patients may be involved in genetic testing to help clarify their risk and guide future treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of paraganglioma or pheochromocytoma, particularly those who may carry genetic variants in the SDH genes.
Not a fit: Patients without a hereditary predisposition to paraganglioma or pheochromocytoma, or those with sporadic cases not linked to genetic factors, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prediction of cancer risk and more personalized treatment plans for patients with hereditary paraganglioma and pheochromocytoma syndrome.
How similar studies have performed: Previous research has shown promise in identifying genetic markers for other hereditary cancers, suggesting that this approach may yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Fishbein, Lauren Michelle — University of Colorado Denver
- Study coordinator: Fishbein, Lauren Michelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.